• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDOS INTERNATIONAL SARL EU ENT4.5MMD 22MML WNO DSTL TP; INTRACRANIAL NEUROVASCULAR STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDOS INTERNATIONAL SARL EU ENT4.5MMD 22MML WNO DSTL TP; INTRACRANIAL NEUROVASCULAR STENT Back to Search Results
Catalog Number ENC452200
Device Problems Premature Activation (1484); Failure to Advance (2524)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/03/2024
Event Type  malfunction  
Event Description
As reported by the field, during an endovascular embolization of the middle cerebral artery, an eu ent4.5mmd 22mml wno dstl tp intracranial stent ( enc452200, 8269486) became impeded in the prowler select plus 150/5cm microcatheter (606s255x, lot unknown) and could not pass through the microcatheter (mc).The physician removed the microcatheter and stent from the patient.The stent was found to be released in the microcatheter and the stent body was separated prematurely from the delivery wire.The stent body was remained in the microcatheter.The doctor switched to new devices to complete the surgery.There was no patient injury reported.Additional event information was received on 11-jan-2024 indicating that the physician did not torque the device.There was no evidence of physical material within the device.The stent was impeded in distal end of the microcatheter.There were no procedural delays.
 
Manufacturer Narrative
Product complaint # : (b)(4).Information regarding patient weight, height, medical history, race, and ethnicity was not reported.Section e1.Initial reporter phone: (b)(6).Section h3 - the device is available to be returned for evaluation and testing.However, it has not been received to date as indicated as ¿other¿ in this section as the reason for non-evaluation.If the device returns, a device investigation will be performed.Missing information from this report is identified as blank; this information was not provided in the reported event or available at the time of report submission.This report is being submitted pursuant to the provisions of 21 cfr, part 803 (and/or part 4, as applicable).This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by cerenovus, or its employees that the report constitutes an admission that the product, cerenovus, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.This is one of two products involved with the complaint and the associated manufacturer report numbers are 3008114965-2024-00081.
 
Manufacturer Narrative
Product complaint(b)(4).Complaint conclusion: as reported by the field, during an endovascular embolization of the middle cerebral artery, an eu ent4.5mmd 22mml wno dstl tp intracranial stent (enc452200, 8269486) became impeded in the prowler select plus 150/5cm microcatheter (606s255x, lot unknown) and could not pass through the microcatheter (mc).The physician removed the microcatheter and stent from the patient.The stent was found to be released in the microcatheter and the stent body was separated prematurely from the delivery wire.The stent body was remained in the microcatheter.The doctor switched to new devices to complete the surgery.There was no patient injury reported.Additional event information was received on 11-jan-2024 indicating that the physician did not torque the device.There was no evidence of physical material within the device.The stent was impeded in distal end of the microcatheter.There were no procedural delays.A non-sterile eu ent4.5mmd 22mml wno dstl tp intracranial stent was received contained in the decontamination pouch.Upon receiving the device, visual inspection was performed and it was noted that the stent component was found detached inside the luer hub of the concomitant microcatheter.The introducer and the delivery wire were not returned for evaluation.The stent was removed from the luer hub of the microcatheter and it was inspected under the magnification, no abnormalities were found on it (i.E.No broken struts, no kinks).Both of the stent ends were noted to be completely expanded.The delivery wire was also inspected and it was found in good normal condition.Lake region medical did review the device history records relative to the manufacturing, inspecting and packaging of the lot 8269486.The history records indicate this product was final inspection tested at lake region medical and was determined to be acceptable.The issue reported regarding the stent being impeded in the microcatheter could not be evaluated due to the detached condition of the stent.This component must still be attached to the delivery wire and inside the introducer to perform a functional analysis; however, the issue reported regarding the stent being prematurely released in the microcatheter was confirmed since the stent was found detached inside the microcatheter's hub.This condition suggests that the enterprise introducer was not fully seated in the hub of the microcatheter, causing the stent to expand in the microcatheter's hub, resulting in the stent component being unable to advance further, where push/pull force was applied sufficiently to disengage the stent from the delivery wire.However, with the amount of information available and the lack of returned components this only remains speculative.As part of the cerenovus quality process, all devices are manufactured, inspected, and released to approved specifications.Since there was no evidence to suggest the event was related to a manufacturing or design issue, no capa activity is required at this time.It should be noted that multiple factors could cause product failure.The instructions for use (ifu) do contain the following recommendations: do not partially deploy the stent from the introducer.Confirm the tip of the delivery wire is entirely within the introducer.As part of the post market surveillance program, information from this complaint is trended to identify statistical signals for consideration of further correction action.Since there was no evidence to suggest the event was related to a manufacturing or design issue, no corrective actions will be taken at this time.A supplemental report will be submitted if new facts arise which materially alter information submitted in a previous mdr report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EU ENT4.5MMD 22MML WNO DSTL TP
Type of Device
INTRACRANIAL NEUROVASCULAR STENT
Manufacturer (Section D)
MEDOS INTERNATIONAL SARL
chemin-blanc 38
le locle neuchatel CH-24 00
SZ  CH-2400
Manufacturer (Section G)
CERENOVUS INC
325 paramount dr
raynham MA 02767
Manufacturer Contact
kate karberg
31 technology dr
irvine, CA 92618
3035526892
MDR Report Key18526975
MDR Text Key333513862
Report Number3008114965-2024-00080
Device Sequence Number1
Product Code NJE
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
H60001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 02/08/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberENC452200
Device Lot Number8269486
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/03/2024
Initial Date FDA Received01/17/2024
Supplement Dates Manufacturer Received01/29/2024
Supplement Dates FDA Received02/08/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/25/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
PROWLER SELECT PLUS 150/5CM
Patient Age58 YR
Patient SexMale
-
-